First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): a... von Eichhorst, Barbara, Dr, Fink, Anna-Maria, MD, Bahlo, Jasmin, PhD, Busch, Raymonde, Dipl Math, Kovacs, Gabor, MD, Maurer, Christian, MD, Lange, Elisabeth, MD, Köppler, Hubert, Prof, Kiehl, Michael, Prof, Sökler, Martin, MD, Schlag, Rudolf, MD, Vehling-Kaiser, Ursula, MD, Köchling, Georg, MD, Plöger, Christoph, MD, Gregor, Michael, MD, Plesner, Torben, MD, Trneny, Marek, Prof, Fischer, Kirsten, MD, Döhner, Harmut, Prof, Kneba, Michael, Prof, Wendtner, Clemens-Martin, Prof, Klapper, Wolfram, Prof, Kreuzer, Karl-Anton, Prof, Stilgenbauer, Stephan, Prof, Böttcher, Sebastian, MD, Hallek, Michael, Prof

Volltext

Vitalism in America: Elihu Palmer's Radical Religion in the Early Republic von Fischer, Kirsten

Volltext

Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG) von Jaramillo, Sonia, Agathangelidis, Andreas, Schneider, Christof, Bahlo, Jasmin, Robrecht, Sandra, Tausch, Eugen, Bloehdorn, Johannes, Hoechstetter, Manuela, Fischer, Kirsten, Eichhorst, Barbara, Goede, Valentin, Hallek, Michael, Döhner, Hartmut, Rosenquist, Richard, Ghia, Paolo, Stamatopoulos, Kostas, Stilgenbauer, Stephan

Volltext

Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia von Al-Sawaf, Othman, Zhang, Can, Jin, Hyun Yong, Robrecht, Sandra, Choi, Yoonha, Balasubramanian, Sandhya, Kotak, Alex, Chang, Yi Meng, Fink, Anna Maria, Tausch, Eugen, Schneider, Christof, Ritgen, Matthias, Kreuzer, Karl-Anton, Chyla, Brenda, Paulson, Joseph N., Pallasch, Christian P., Frenzel, Lukas P., Peifer, Martin, Eichhorst, Barbara, Stilgenbauer, Stephan, Jiang, Yanwen, Hallek, Michael, Fischer, Kirsten

Volltext

Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Rando... von BÖTTCHER, Sebastian, RITGEN, Matthias, MENDILA, Myriam, WENDTNER, Clemens-Martin, EICHHORST, Barbara F, DÖHNER, Hartmut, HALLEK, Michael J, KNEBA, Michael, FISCHER, Kirsten, STILGENBAUER, Stephan, BUSCH, Raymonde M, FINGERLE-ROWSON, Günter, FINK, Anna Maria, BÜHLER, Andreas, ZENZ, Thorsten, WENGER, Michael Karl

Volltext

Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukem... von FISCHER, Kirsten, CRAMER, Paula, KRANZ, Gabriele, GOEDE, Valentin, ELTER, Thomas, BÜHLER, Andreas, WINKLER, Dirk, KNEBA, Michael, DÖHNER, Hartmut, EICHHORST, Barbara F, HALLEK, Michael, WENDTNER, Clemens-Martin, BUSCH, Raymonde, STILGENBAUER, Stephan, BAHLO, Jasmin, SCHWEIGHOFER, Carmen D, BOTTCHER, Sebastian, STAIB, Peter, KIEHL, Michael, ECKART, Michael J

Volltext

Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leuke... von FISCHER, Kirsten, CRAMER, Paula, TRESCKOW, Julia Von, FINK, Anna-Maria, BÜHLER, Andreas, WINKLER, Dirk, KREUZER, Karl-Anton, STAIB, Peter, RITGEN, Matthias, KNEBA, Michael, DÖHNER, Hartmut, EICHHORST, Barbara F, BUSCH, Raymonde, HALLEK, Michael, STILGENBAUER, Stephan, WENDTNER, Clemens-Martin, BÖTTCHER, Sebastian, BAHLO, Jasmin, SCHUBERT, Jöerg, PFLÜGER, Karl H, SCHOTT, Silke, GOEDE, Valentin, ISFORT, Susanne

Volltext

A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL von Dimier, Natalie, Delmar, Paul, Ward, Carol, Morariu-Zamfir, Rodica, Fingerle-Rowson, Günter, Bahlo, Jasmin, Fischer, Kirsten, Eichhorst, Barbara, Goede, Valentin, van Dongen, Jacques J.M., Ritgen, Matthias, Böttcher, Sebastian, Langerak, Anton W., Kneba, Michael, Hallek, Michael

Volltext

Venetoclax and obinutuzumab in chronic lymphocytic leukemia von Fischer, Kirsten, Al-Sawaf, Othman, Fink, Anna-Maria, Dixon, Mark, Bahlo, Jasmin, Warburton, Simon, Kipps, Thomas J., Weinkove, Robert, Robinson, Sue, Seiler, Till, Opat, Stephen, Owen, Carolyn, López, Javier, Humphrey, Kathryn, Humerickhouse, Rod, Tausch, Eugen, Frenzel, Lukas, Eichhorst, Barbara, Wendtner, Clemens-M., Stilgenbauer, Stephan, Langerak, Anton W., van Dongen, Jacque J.M., Böttcher, Sebastian, Ritgen, Matthias, Goede, Valentin, Mobasher, Mehrdad, Hallek, Michael

Volltext

Learning Interacting Theories from Data von Merger, Claudia, René, Alexandre, Fischer, Kirsten, Bouss, Peter, Nestler, Sandra, Dahmen, David, Honerkamp, Carsten, Helias, Moritz

Volltext

Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia von Bloehdorn, Johannes, Braun, Andrejs, Taylor-Weiner, Amaro, Jebaraj, Billy Michael Chelliah, Robrecht, Sandra, Krzykalla, Julia, Pan, Heng, Giza, Adam, Akylzhanova, Gulnara, Holzmann, Karlheinz, Scheffold, Annika, Johnston, Harvey E., Yeh, Ru-Fang, Klymenko, Tetyana, Tausch, Eugen, Eichhorst, Barbara, Bullinger, Lars, Fischer, Kirsten, Weisser, Martin, Robak, Tadeusz, Schneider, Christof, Gribben, John, Dahal, Lekh N., Carter, Mathew J., Elemento, Olivier, Landau, Dan A., Neuberg, Donna S., Cragg, Mark S., Benner, Axel, Hallek, Michael, Wu, Catherine J., Döhner, Hartmut, Stilgenbauer, Stephan, Mertens, Daniel

Volltext

Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymph... von Al-Sawaf, Othman, Zhang, Can, Jin, Hyun Yong, Robrecht, Sandra, Choi, Yoonha, Balasubramanian, Sandhya, Kotak, Alex, Chang, Yi Meng, Fink, Anna Maria, Tausch, Eugen, Schneider, Christof, Ritgen, Matthias, Kreuzer, Karl-Anton, Chyla, Brenda, Paulson, Joseph N., Pallasch, Christian P., Frenzel, Lukas P., Peifer, Martin, Eichhorst, Barbara, Stilgenbauer, Stephan, Jiang, Yanwen, Hallek, Michael, Fischer, Kirsten

Volltext

Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription von Edelmann, Jennifer, Holzmann, Karlheinz, Tausch, Eugen, Saunderson, Emily A, Jebaraj, Billy M C, Steinbrecher, Daniela, Dolnik, Anna, Blätte, Tamara J, Landau, Dan A, Saub, Jenny, Estenfelder, Sven, Ibach, Stefan, Cymbalista, Florence, Leblond, Veronique, Delmer, Alain, Bahlo, Jasmin, Robrecht, Sandra, Fischer, Kirsten, Goede, Valentin, Bullinger, Lars, Wu, Catherine J, Mertens, Daniel, Ficz, Gabriella, Gribben, John G, Hallek, Michael, Döhner, Hartmut, Stilgenbauer, Stephan

Volltext

Decomposing neural networks as mappings of correlation functions von Fischer, Kirsten, René, Alexandre, Keup, Christian, Layer, Moritz, Dahmen, David, Helias, Moritz

Volltext

GENOMIC ORGANIZATION OF THE MAMMALIAN MHC von Kumánovics, Attila, Takada, Toyoyuki, Lindahl, Kirsten Fischer

Volltext

SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia von Mellinghoff, Sibylle C., Mayer, Leonie, Robrecht, Sandra, Weskamm, Leonie M., Dahlke, Christine, Gruell, Henning, Schlotz, Maike, Vanshylla, Kanika, Schloser, Hans A., Thelen, Martin, Fink, Anna-Maria, Fischer, Kirsten, Klein, Florian, Addo, Marylyn M., Eichhorst, Barbara, Hallek, Michael, Langerbeins, Petra

Volltext

Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients von Bloehdorn, Johannes, Krzykalla, Julia, Holzmann, Karlheinz, Gerhardinger, Andreas, Jebaraj, Billy Michael Chelliah, Bahlo, Jasmin, Humphrey, Kathryn, Tausch, Eugen, Robrecht, Sandra, Mertens, Daniel, Schneider, Christof, Fischer, Kirsten, Hallek, Michael, Döhner, Hartmut, Benner, Axel, Stilgenbauer, Stephan

Volltext

Bendamustine, followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia (CLL2-BIO): primary endpoint analysis of a multicenter, open-label phase-II trial von Cramer, Paula, Tresckow, Julia V, Robrecht, Sandra, Bahlo, Jasmin, Fürstenau, Moritz, Langerbeins, Petra, Pflug, Natali, Al-Sawaf, Othman, Heinz, Werner J, Vehling-Kaiser, Ursula, Dürig, Jan, Tausch, Eugen, Hensel, Manfred, Sasse, Stephanie, Fink, Anna-Maria, Fischer, Kirsten, Kreuzer, Karl-Anton, Böttcher, Sebastian, Ritgen, Matthias, Kneba, Michael, Wendtner, Clemens-Martin, Stilgenbauer, Stephan, Eichhorst, Barbara, Hallek, Michael

Volltext

Quantitative Analysis of Minimal Residual Disease (MRD) Shows High Rates of Undetectable MRD after Fixed-Duration Chemotherapy-Free Treatment and Serves As Surrogate Marker for Pro... von Fischer, Kirsten, Ritgen, Matthias, Al-Sawaf, Othman, Robrecht, Sandra, Tandon, Maneesh, Fink, Anna-Maria, Schilhabel, Anke, Stübig, Thomas, Brüggemann, Monika, Jiang, Yanwen, Schary, William, Eichhorst, Barbara F., Wendtner, Clemens-Martin, Tausch, Eugen, Kreuzer, Karl-Anton, Langerak, Anton W, Goede, Valentin, Böttcher, Sebastian, Stilgenbauer, Stephan, Kneba, Michael, Hallek, Michael

Volltext

Venetoclax plus rituximab or obinutuzumab after allogeneic hematopoietic stem cell transplantation in chronic lymphocytic leukemia von Al-Sawaf, Othman, Herling, Carmen Diana, Holtick, Udo, Scheid, Christoph, Cramer, Paula, Sasse, Stephanie, von Tresckow, Bastian, Tuchscherer, Armin, Fischer, Kirsten, Eichhorst, Barbara, Hallek, Michael, Frenzel, Lukas P

Volltext